A detailed history of Fulcrum Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Fulcrum Capital LLC holds 49,243 shares of ZTS stock, worth $8.71 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares
49,243
Previous 48,601 1.32%
Holding current value
$8.71 Million
Previous $8.43 Million 14.2%
% of portfolio
2.13%
Previous 1.95%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$172.58 - $196.48 $110,796 - $126,140
642 Added 1.32%
49,243 $9.62 Million
Q2 2024

Jul 22, 2024

BUY
$145.54 - $178.83 $375,784 - $461,739
2,582 Added 5.61%
48,601 $8.43 Million
Q1 2024

Apr 17, 2024

BUY
$165.67 - $199.94 $119,613 - $144,356
722 Added 1.59%
46,019 $7.79 Million
Q4 2023

Jan 10, 2024

SELL
$151.44 - $200.09 $112,974 - $149,267
-746 Reduced 1.62%
45,297 $8.94 Million
Q3 2023

Oct 13, 2023

SELL
$167.14 - $192.77 $9,192 - $10,602
-55 Reduced 0.12%
46,043 $8.01 Million
Q2 2023

Jul 27, 2023

SELL
$160.94 - $186.23 $482,176 - $557,945
-2,996 Reduced 6.1%
46,098 $7.94 Million
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $40,879 - $49,180
281 Added 0.58%
49,094 $8.17 Million
Q4 2022

Jan 24, 2023

BUY
$131.14 - $157.47 $153,564 - $184,397
1,171 Added 2.46%
48,813 $0
Q3 2022

Oct 17, 2022

SELL
$148.29 - $182.55 $195,297 - $240,418
-1,317 Reduced 2.69%
47,642 $7.07 Million
Q2 2022

Aug 03, 2022

BUY
$155.97 - $200.09 $163,144 - $209,294
1,046 Added 2.18%
48,959 $8.42 Million
Q1 2022

May 05, 2022

BUY
$181.39 - $234.03 $226,918 - $292,771
1,251 Added 2.68%
47,913 $9.04 Million
Q4 2021

Jan 25, 2022

BUY
$193.69 - $247.03 $92,583 - $118,080
478 Added 1.03%
46,662 $11.4 Million
Q3 2021

Oct 21, 2021

BUY
$189.29 - $209.69 $66,630 - $73,810
352 Added 0.77%
46,184 $8.97 Million
Q2 2021

Jul 30, 2021

BUY
$155.9 - $187.99 $371,042 - $447,416
2,380 Added 5.48%
45,832 $8.54 Million
Q1 2021

Apr 12, 2021

BUY
$144.0 - $169.39 $279,072 - $328,277
1,938 Added 4.67%
43,452 $6.84 Million
Q4 2020

Feb 09, 2021

BUY
$157.07 - $174.35 $352,936 - $391,764
2,247 Added 5.72%
41,514 $6.87 Million
Q3 2020

Oct 21, 2020

SELL
$137.1 - $165.37 $969,434 - $1.17 Million
-7,071 Reduced 15.26%
39,267 $6.49 Million
Q2 2020

Jul 27, 2020

SELL
$111.92 - $142.53 $454,954 - $579,384
-4,065 Reduced 8.06%
46,338 $6.35 Million
Q1 2020

May 01, 2020

SELL
$92.66 - $144.94 $229,611 - $359,161
-2,478 Reduced 4.69%
50,403 $5.93 Million
Q4 2019

Feb 03, 2020

BUY
$116.25 - $133.25 $216,457 - $248,111
1,862 Added 3.65%
52,881 $7 Million
Q3 2019

Oct 31, 2019

SELL
$112.57 - $128.43 $110,431 - $125,989
-981 Reduced 1.89%
51,019 $0
Q2 2019

Jul 29, 2019

BUY
$97.98 - $114.28 $5.09 Million - $5.94 Million
52,000 New
52,000 $5.9 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Fulcrum Capital LLC Portfolio

Follow Fulcrum Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.